John F. Reinus
<FONT color=#000000>Clinical practice limited to liver diseases. Research on liver diseases and related topics.</FONT>
<p> </p>
<ol>
<li>Gaglio P, Moss N, McGaw C, Reinus JF. Direct-acting antiviral therapy for hepatitis C: Attitudes regarding future use. Dig Dis Sci. 2011; 56:1509-1515.</li>
<li>Flattau A, Olaywi M, Gaglio PJ, Marcus P, Meissner P, L Dorfman EB, Reinus JF. Social barriers to listing for adult liver transplantation: Their prevalence and association with program characteristics. Liver Transpl. 2011; 17:1167-1175.</li>
<li>Golowa YS, Cynamon J, Reinus JF, Kinkhabwala M, Abrams M, Jagust M, Chernyak V, Kaubisch A. Value of noncontrast CT immediately after transarterial chemoembolization of hepatocellular carcinoma with drug-eluting beads. J Vasc Interv Radiol. 2012; 23:1031-1035.</li>
<li>Schwartz JM, Reinus JF. Prevalence and natural history of alcoholic liver disease. Clin Liver Dis. 2012; 16:659-666. Review.</li>
<li>Kinkhabwala M, Lindower J, Reinus JF, Principe AL, Gaglio PJ. Expedited liver allocation in the United States: a critical analysis. Liver Transpl. 2013; 19: 1159-1165.</li>
<li>Bichoupan K, Schwartz JM, Martel-Laferriere V, Giannattasio ER, Marfo K, Odin JA, Liu LU, Schiano TD, Perumalswami P, Bansal M, Gaglio PJ, Kalia H, Dieterich DT, Branch AD, Reinus JF. Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir. Aliment Pharmacol Ther. 2014; 39:209-216.</li>
<li>Izzy M, Jibara G, Aljanabi A, Alani M, Giannattasio E, Zaidi H, Said Z, Gaglio P, Wolkoff A, Reinus JF. Limited fibrosis progression but significant mortality in patients ineligible for interferon-based hepatitis C therapy. J Clin Exp Hepatol. 2016 Jun;6(2):100-8.</li>
<li>Chacko KR, Reinus J. Spectrum of alcoholic liver disease. Clin Liver Dis. 2016 Aug;20(3):419-27.</li>
<li>Chacko KR, Reinus J. Extrahepatic complications of nonalcoholic fatty liver disease. Clin Liver Dis. 2016 May;20(2):387-401. Review.</li>
</ol>
<p> </p>
<p>John F. Reinus, MD, is Emeritus Medical Director, Liver Transplantation and Professor, Medicine at Montefiore Einstein. His work centers on liver transplantation, end-stage liver disease and viral hepatitis.</p><p>Dr. Reinus studied Pre-Medical Sciences at Columbia University before earning his Doctor of Medicine at Cornell Medical College in 1981. He then began an internal medicine internship at Bellevue Hospital Center, completing it in 1982. Following this, Dr. Reinus completed a residency in internal medicine at the same institution in 1984 before completing a hepatology fellowship at Emory University School of Medicine in 1985. He went on to complete a fellowship in gastroenterology at the same institution, finishing it in 1987. Dr. Reinus then completed a Transplant Hepatology Preceptorship at the Center for Liver Disease and Transplantation in 2006.</p><p>Building on his clinical focus, Dr. Reinus’ research is focused on liver diseases and related topics. His work has been published in peer-reviewed journals, books, chapters, reviews and abstracts, and he has presented at numerous conferences and meetings.</p><p>Dr. Reinus is board certified by the American Board of Medical Examiners in Internal Medicine, Gastroenterology and Transplant Hepatology. He is a fellow of the American Association for the Study of Liver Diseases and a member of the American Gastroenterological Association and the American Society of Transplantation.</p>